CD79A and breast cancer: Here, we utilized residual sera collected from routine antenatal screening in BC to investigate the SARS-CoV-2 and HCoV IgA and IgG antibody responses in vaccinated and unvaccinated pregnant individuals over 3 months following SARS-CoV-2 infection.